The discordance in results between independent genome-wide association studies (GWAS) indicates the potential for Type I and Type II errors. To identify the causes of variability underlying lack of reproducibility, here we present the results of a repeatability experiment on GWAS on a cohort of 1991 coronary artery disease individuals and 1500 controls (National Blood Service) provided by the Wellcome Trust Case Control Consortium. As part of the MicroArray Quality Control project, we identified quality control (QC) and association analysis steps with a major impact on the identification of candidate markers for possible classifiers. Different experimental conditions were used with the CHIAMO calling algorithm to assess the effects of batch size and case-control composition on downstream association analysis. Results showed that both composition and size create discordant singlenucleotide polymorphism (SNP) results for QC and statistical analysis and may contribute to the lack of reproducibility in GWAS. An interactive effect of batch size and composition contributes to discordant results in significantly associated loci. About 800 significant SNPs (Cochran-Armitage trend test, Po5.0 Â 10 À7 ) were found for batches of 2000 samples with separated cases and controls, whereas only 14 significant markers were found with one batch of all samples.
Introduction
Genome-wide association studies (GWAS) aim to identify genetic variants (typically single-nucleotide polymorphisms (SNPs)) across the human genome that might be involved in disease susceptibility or resistance. A growing number of GWAS with increasing size and scope has been performed, [1] [2] [3] [4] indicating that the technology is a promising field of research for associating genotypes with a variety of phenotypes and health outcomes. However, the lack of repeatability, which was proved for gene expression microarrays by a recent study, 5 is a critical issue also in GWAS, as shown by a number of replication and meta-analysis studies. [6] [7] [8] [9] [10] [11] [12] The complex design of GWAS introduces multiple sources of Type I and Type II errors, whose interaction adds to the intrinsic difficulty in separating true risk variants from statistical noise, given the hundreds of thousands of variants that are usually considered. GWAS heavily rely on the 'common disease, common variant' assumption, which implies that the genetic risk for common diseases depends on the contribution of a relatively small number of common genetic variants. To claim a potentially true association, GWAS must have a large enough sample size to achieve adequate statistical power, as well as a replication step built-in in the study design. 13 Besides sample sizes, independent follow-up studies often failed to replicate initial findings because of flaws or biases either in the original study or in the replication. 9, 14 Although even consistent replication cannot exclude false-positive associations that may be induced by biases common to replication studies, GWAS design has gradually improved since early studies, with larger sample sizes and multitiered replication within consortium-coordinated efforts. 15 A similar progress regarded the accuracy of the genotype calling algorithms, but still minimal design errors can introduce bias that inflates both Type I and Type II error rates, thus confirming the need for a careful quality control (QC). 16 Many GWAS are based on the Affymetrix (Santa Clara, CA, USA) GeneChip Mapping 500K array set (Affy500K). 2, 17, 18 Genotypes for the Affy500K are usually called by the BRLMM algorithm, 19 recommended by Affymetrix, although several algorithms have been developed by third-party laboratories, such as SNiPer-HD, 20 CRLMM 21 and CHIAMO. 2 The latter achieves genotype calls by a Bayesian hierarchical mixture model and was previously adopted in the major Wellcome Trust Case Control Consortium (WTCCC) study.
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A recent study, 22 using 270 HapMap samples genotyped on the Affy500K, has shown that discordant GWAS results can arise because of differences in both batch size (the number of samples called simultaneously) and batch composition (combining or separating different populations in batch sets). Batches of either different sizes or compositions were shown to have high (499.9%) concordance rates for the genotype calls, although exhibiting significant differences in call rate results at both sample and SNP levels. The use of larger batch sizes and homogeneous sample compositions emerged as a main recommendation, highlighting the influence of batch effects on the outcome of a GWAS. These results showed the need of a better understanding of batch effect behavior in genotype calling algorithms for GWAS with thousands of individuals. In this study, we extend the evaluations of batch effects and the implications on further downstream analysis of a casecontrol study.
We evaluated the effects of different batch sizes and casecontrol compositions on the outcome of GWAS results with 1991 cases for coronary artery disease (CAD) and 1500 controls from the WTCCC genotyped with the CHIAMO calling algorithm. Our results show that the set of markers that pass QC, as well as the list of markers deemed significant by association tests, are influenced by both batch size and case-control composition. An evaluation of subjectspecific differences in the probabilities for an SNP to pass QC or to be deemed significant reported a strong effect of batch composition, as well as an interactive effect of size and composition on GWAS.
Materials and methods

WTCCC data
Raw intensity data (CEL files) were obtained from the WTCCC. 2 In this study, 1991 cases for CAD and 1500 individuals from the UK National Blood Service (NBS) control group were considered. All individuals were genotyped with Affymetrix GeneChip Mapping 500K Array Set (Affy500K), consisting of two arrays (Nsp and Sty), each capable of genotyping 250 000 SNPs on average, for a total of 500 568 SNPs overall.
Data normalization
Affymetrix probe intensity data underwent a quantile normalization step to minimize chip-to-chip variability. The software CelQuantileNorm (v2008-07-06, http:// outmodedbonsai.sourceforge.net), originally developed by Hin-Tak Leung within the WTCCC study, 2 was used for this purpose. The latest release (revision 4 at the time of writing) of Chip Descriptor Files, describing the layout for the 500K array, was used for normalizing CEL files and was downloaded from the Affymetrix website. Normalization was performed on Nsp and Sty arrays separately, and the results were merged. The output of CelQuantileNorm consists of a tab-delimited text file for each chromosome, with SNPs as rows and normalized intensities of allele A and B for all samples as columns. Affymetrix 500K annotations were also included for each SNP.
Genotype calling
Genotypes were called from normalized intensities by using CHIAMO (v0.2.1, http://www.stats.ox.ac.uk/~marchini/software/ gwas/chiamo.html), a software developed within the WTCCC project and adopted to call genotypes for the GWAS previously reported. 2 . One of the key features of CHIAMO is the simultaneous genotype calling from all individuals. In addition, it can be run on multiple cohorts (for example, cases and controls), each with potentially different intensity characteristics. A Bayesian hierarchical four-class (AA, AB, BB and null) mixture model is used to call genotypes: the algorithm starts from twelve random starting points and finds the optimal set of parameters by maximizing the posterior distribution of the model. The output of the algorithm consists of a text file with the maximum a posteriori estimates of the probabilities of each genotype being AA, AB or BB for each sample. By exploiting the capability of CHIAMO to genotype SNPs in chunks, the software was adapted to run on a distributed memory Linux cluster controlled by Sun Grid Engine job scheduler, using up to 312 computing cores. In detail, the number of SNPs of each chromosome was split equally into N chunks to be processed by N computing cores in parallel. Overall, genotype calling was run on 30 CPUs on average and took about 270 h per CPU.
Batch effect schema WTCCC raw data were normalized and genotyped according to several batch configurations, to assess the effects of size (that is, the number of samples processed simultaneously) and composition (that is, the case-to-control ratio in a batch) on called genotypes, and their propagation to the list of significantly associated SNPs found. Three experiments were conducted to assess the effect of batch size by partitioning the data set in batches with (approximately) 500, 2000 and 3500 samples each. Two experiments were performed to study the effect of batch composition by placing cases and controls in separate batches (S) and in combined batches (C) with a 1.25:1 case-to-control ratio. The samples were assigned to batches according to the alphabetical order of sample IDs. Overall, 5 different partitions of the 3491 samples were considered: C500, a combined data set of approximate size 500 consisting of 6 batches with 285 CAD and 215 NBS each, plus one batch with 281 CAD and 215 NBS; C2000, a combined data set of approximate size 2000 consisting of 2 batches with 995 CAD and 750 NBS each; C3500, a single combined batch comprising all 3491 samples; S500, a separated data set consisting of 4 batches of 500 CAD each (except one batch of 491 samples) and 3 batches of 500 NBS each; and S2000, a separated data set formed by one batch of 1991 CAD and 1500 NBS.
QC
Downstream analysis was performed with PLINK (v1.06, http://pngu.mgh.harvard.edu/~purcell/plink), an opensource whole-genome association analysis software. 23 Ad hoc Python scripts were written to convert genotype files output by CHIAMO into standard LINKAGE pedigree format and import them in PLINK for further analysis. The QC procedure that was adopted for each data set reproduced the QC carried out in the WTCCC study. 2 First, filters were applied to individuals: samples with a call rate o97% were excluded, as well as individuals whose heterozygosity was o25% or 430%. Then QC was performed at an SNP level: first, SNPs with a minor allele frequency o1% were excluded; second, markers having call rate o5% were filtered out; then, the remaining SNPs were excluded on the basis of differential missingness in cases and controls assessed by Fisher's exact test. As final QC step, we filtered out markers that failed the Hardy-Weinberg equilibrium exact test in controls. Significance thresholds for both Fisher and Hardy-Weinberg equilibrium tests were set to P ¼ 5.7 Â 10 -7 , as described in the WTCCC paper. 
Association analysis
Significant association between disease status (CAD) and markers that passed QC was assessed with PLINK using the Cochran-Armitage 1 d.f. trend test. 24 Association was considered significant if the test P-value was o5.0 Â 10 À7 , an empirical threshold previously proposed.
2 Association quantile-quantile (Q-Q) plots were computed for different batch configurations and compared with areas of 95% probability. 2 
GLMMs
Generalized linear mixed models (GLMMs) were used to estimate the potential subject-specific effects of batch size, composition, and their interaction with the probability of an SNP being excluded by QC (Model I) and the probability of an SNP being deemed significant at Po1.0 Â 10 À5 (Model II). The GLMM is given by
where X is the model matrix for fixed effects (that is, size and composition), Z the model matrix for the random effect (that is, SNP), b a vector of unknown parameters (fixed effects) and g a vector of random effects. As for the SNP random effect, we assume that g i AN(0,s s 2 ). The response for Model I is coded as y 1 ¼ 0 for each SNP that passed QC, and y 1 ¼ 1 for each SNP that failed QC; the response for Model II is coded as y 2 ¼ 0 for each SNP that passed QC but was not significant, and y 2 ¼ 1 for each SNP deemed significant at Po1.0 Â 10 -5 .
Results
Five partitions of the WTCCC data set were generated by considering different sizes and compositions (see Materials and methods): C500, C2000, C3500, S500 and S2000. The data set labels represent batch composition (combined or separate cases and controls) and approximate size (500, 2000, 3500) used to both normalize and genotype data with CHIAMO algorithm. All the data sets underwent the same QC and association testing procedures.
QC
For each of the five data sets C500, C2000, C3500, S500 and S2000, the counts of excluded individuals and markers at each QC step are reported in Figures 1 and 2 . We note that the number of individuals with low (o97%) genotyping rate slightly increases with data set size, regardless of the data set composition. One sample did not pass the heterozygosity filter for all five data sets, namely, 12707B11 (CAD, male; average heterozygosity±s.d. across all data sets: 18.90 ± 0.08%). Similarly, the number of SNPs excluded because of low minor allele frequency or low genotyping rate is increasing with respect to batch size. As far as batch composition effect is considered, differences in call rates between cases and controls were found to be statistically significant for a larger number of SNPs when cases and controls were preprocessed in separate batches. The number of markers failing Hardy-Weinberg equilibrium test showed a decreasing trend with respect to both batch size and composition, being lower for combined data sets. Overall, the QC procedure tended to exclude less SNPs as batch size increased.
Association testing
The P-values resulting from the genome-wide association tests are shown in Àlog 10 scale as Manhattan plots ( Figure 3 ) and scatter plot matrix (Figure 4 ) for each data set. A list of Batch size and composition give discordant results in GWAS M Chierici et al the top significant markers for the C3500 batch set is shown in Table 1 ; we note that the list includes the variant rs1333049 on chromosome 9p21, previously reported 2 as associated with CAD. Overall, a strong association on chromosome 9 was found among all data sets (see Figure 3) . The highest concordance of association results was found between C2000 and C3500 data sets, whereas the highest discordance was found between S2000 and remaining data sets. It should be noted that, in general, separation of cases and controls increased the discordance. The influence of batch variations on genotype calls that are statistically significant was studied. Batch size and composition give discordant results in GWAS have been made to investigate the effect of batch size (C500 vs C2000, C500 vs C3500, S500 vs S2000) and batch composition (C500 vs S500, C2000 vs S2000) on the lists of significant SNPs. The number of nonoverlapping SNPs clearly indicates a batch effect that can produce discordant lists of significant markers from the same raw allele intensities. This is particularly evident for S2000 and S500 batches. The sources of discordance that yield the nonoverlapping regions in the Venn diagrams can be further analyzed. In fact, they can be either due to QC (that is, an SNP excluded by QC in one batch set, but present and found significant in another) or to differential association test results (that is, an SNP that passed QC in both data sets and was found significant only in one set). These sources of discordance are summarized in the stacked histogram of Figure 5 ; for each pairwise batch set comparison, the fraction of discordant SNPs due to QC exclusion or association testing is reported. Moreover, batch effects due to both size and composition are highlighted by the Q-Q plots in Figure 6 , showing a differential divergence from the expected w 2 distribution. Although Q-Q plots for C3500, C2000 and C500 show a similar profile, Q-Q plots for S500 and S2000 begin to stray for lower values of the expected distribution, with respect to the combined data sets.
Statistical tests for batch effects
The statistical impact of batch size and composition on QC and association analysis was evaluated by fitting a GLMM, modelling the probability of an SNP being excluded by QC (Model I) or deemed significant (Model II) for Po1.0 Â 10 -5 , significance threshold that was previously proposed 2 as an additional cutoff for moderate significance. The outcome of Model I was coded as 0 for each SNP that passed QC and 1 for each SNP that was filtered out; in a similar way, the outcome of Model II was coded as 0 for each SNP that passed QC but was not significant, and 1 for each SNP found significant. Size and composition were assumed as fixed effects; in addition, as the same SNP was genotyped in each of the batch sets, a random effect described by an SNP identifier was added to the GLMM. To achieve a balanced design, C3500 was not included in the models. The GLMM design matrix and parameter vector for the fixed batch effects are shown in Table 2 . A set of seven hypotheses was tested on both Model I and Model II: three main tests were performed to assess the effects of size, composition and size x composition interaction; four additional hypotheses tested for different interaction effects stratified over all batch size and composition levels. The results of the tests in terms of odds ratio (OR) estimates for each contrast are detailed in Table 3 . The high positive estimate for the '500 vs 2000' contrast indicates that there is a higher probability for an SNP to be excluded by QC in batch sets of size 500 than 2000; moreover, the probability of an SNP to be filtered out is higher in separate than in combined data sets, given the large negative estimate for the 'Combined vs Separate' contrast. A moderate interaction effect of both size and composition on the QC outcome is proved by the contrast 'Size Â Composition' (OR ¼ 0.371 at P50.001). The 
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M Chierici et al and controls at a batch size of 2000 yields a much higher probability of an SNP being excluded by QC. For Model II, the interaction 'Size Â Composition' effect is almost negligible (OR ¼ À0.001 at P ¼ 0.99), as well as the '500 vs 2000' effect for combined data sets (OR ¼ 0.361 at P ¼ 0.18). A moderate effect of batch size was reported (OR ¼ 0.362 at P ¼ 0.18 for '500 vs 2000' contrast), resulting in more SNPs likely to be found significant at a batch size of 500. A strong impact of batch composition was reported for both main effect (OR ¼ À1.355, 'Combined vs Separate') and interaction effects (OR ¼ À1.355, À1.353 for size 500 and 2000, respectively), indicating that the probability of significant findings is much higher when cases are processed separately from controls.
The subset of discordant outcomes for SNPs across the four batch sets was relatively low. Overall concordance for the outcome of an SNP to pass QC or to be excluded in all four batch sets was 91.18%. Overall concordance in association testing (at Po1.0 Â 10 -5 significance threshold) for SNPs that passed QC in all four batch sets was 99.95%; taking into account differential QC results, overall concordance in association testing dropped to 89.27%. In GWAS with 4500 000 SNPs, these discordance rates can drastically change the outcome of association testing, as they translate to thousands of markers being affected by batch effects.
Discussion
We demonstrate that batch size and composition introduce a large variability on both the QC process and the final list of significantly associated SNPs for GWAS data, using the WTCCC CAD data set as an example. As summarized in Figures 1 and 2 , increasing the batch size from 500 to 2000 or 3500 results in less SNPs being excluded from analysis under typical QC thresholds (from 118500 in S500 to 92026 in C3500), as well as differential sets of SNPs that pass QC. Moreover, the effect of batch composition is more prominent at a batch size of 2000 rather than 500, with the S2000 Figure 5 Analysis of discordance among significant (at Po5 Â 10 -7 ) SNPs, for pairwise comparisons of C500 vs C2000, C500 vs C3500, S500 vs S2000, C500 vs S500 and C2000 vs S2000, respectively. The bars represent the fractions of discordant significant SNPs because of QC exclusion or differential association test results. The legend refers to the order induced by the comparison label on the x-axis. batch set yielding the highest discordant results. Changes in batch size and composition severely affect association testing results, not only because of the differential sets of SNPs that passed QC, but also because of different trends in the magnitude of P-values as seen in Figures 3 and 4 . As a result, the discordance of QC and P-value results propagates to the lists of SNPs deemed significant at different batch sets, as evidenced in Figure 5 .
Using GLMMs, we confirm that batch size and composition effects have a highly significant impact on the results of GWAS, the highest discordance being found for the S2000 data set (Table 3 ). These results suggest that the CHIAMO genotyping algorithm is mostly sensitive to the case-control batch composition rather than to batch size. This may be explained by the fact that the algorithm was optimized for calling genotypes on multiple cohorts simultaneously, allowing for correlation between the model parameters of each cohort. 2 Recent research 25 proposed the use of modified normalization steps for better genotype calls with the method CRLMM. Additional studies are needed to investigate how batch configuration affects the results of alternative genotype calling algorithms.
The evidence that batch size and composition differences affect the CHIAMO algorithm exhibits a potential major source for lack of reproducibility in GWAS. Batches with more individuals with cases and controls combined resulted in more concordant association testing results, thus indicating a lower probability of Type I errors. On the other hand, the exclusion of more markers by QC with this schema could result in an increase of Type II errors, as it is possible to miss a true association in an SNP that was previously excluded by QC thresholds. An opposite behavior was observed for smaller batch sizes with cases and controls separated, in which the high number of positive findings indicates a higher probability of Type I errors, with the significant markers being more likely spurious associations. It is therefore advisable, whenever computational resources do not allow the analysis of a single batch with all samples, to split the samples in batches with smaller size, but keep the cases and controls combined in each batch.
In this study, an additional GWAS was conducted on a data set of 898 cases for CAD and 981 controls from the University of Ottawa Heart Institute, genotyped on the Affy500K. The data were processed as a single combined Table 3 Estimates and P-values for two GLMMs testing for significant subject-specific differences in either QC exclusion or trend test results between batch size and composition levels
Contrast
Hypothesis Model Estimate P-value 500 vs 2000
À2
Combined vs separate H 0 : Abbreviations: GLMM, generalized linear mixed model; QC, quality control; SNP, single-nucleotide polymorphism. The estimates are expressed as log odd ratios associated with the contrast. 'excl' indicates the random effects modelling of the probability that an SNP was excluded by QC; 'signif' indicates the modelling of the probability that an SNP was found significant at Po10 Â 10 À5 . Abbreviation: GLMM, generalized linear mixed model.
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M Chierici et al batch and underwent the same CHIAMO genotype calling, QC and association testing procedures that were applied to the WTCCC data set. Although the number of samples and markers excluded by QC compared well with the WTCCC C3500 batch set (results not shown), it has to be noted here that no analogous strong association on chromosome 9 was found neither at P ¼ 5.0 Â 10 -7 or P ¼ 1.0 Â 10 -5 significance thresholds (results not shown). This can be due to the reduced sample size that makes the statistical power inadequate to detect a strong effect. If moderate effects in GWAS are to be detected, then large sample sizes are needed to avoid the lack of statistical power; on the other hand, large sample sizes introduce genotype calling issues and inconsistencies when samples are processed by batches in case of limited computing resources.
Significance rules based on P-value cutoffs are not designed to be reproducible, but rather to control Type I and Type II errors. A similar issue of discordance was found in the MicroArray Quality Control project 26 in the context of gene expression. A primary recommendation of that study was that filtering on both P-value and fold change criterion can lead to more reproducible results. This suggests that adding a further criterion to current P-value filtering rules could enhance the reproducibility of genome-wide association testing results.
In conclusion, it is recommended to use a combined batch composition schema in studies in which cases and controls are prepared by the same or similar laboratories and randomly assigned to plates for processing, to avoid differential bias due to varying patterns of data in cases and controls. Another possible approach would be to consider the allele probe intensities directly to avoid genotype calling errors. Future research on the sources of variability in GWAS for other popular calling algorithms, such as Birdseed and CRLMM, is a necessary step to allow an informed choice of genotyping platform and calling algorithm and is currently under investigation by the MicroArray Quality Control GenomeWide Association Working Group.
